The tube, cap, and multi-tube unit consumables are critical for performing molecular diagnostic tests on the Panther and Panther Fusion systems. This investment will increase Hologic's production from 4.8 million COVID-19 tests per month to 6.8 million tests per month. Hologic Inc. is expected to deliver the increased volume of consumables to market by January 2021.
“The Trump Administration’s coordination across the Federal government is important toward the successful execution of our national testing strategy to fight COVID-19,” said HHS Assistant Secretary for Health ADM Brett Giroir, M.D. “Hologic’s platform is in high demand, and with this investment, we will be able to improve the supply to laboratories across the country.”
The unprecedented demand for molecular diagnostic testing driven by the COVID-19 pandemic had exceeded Hologic Inc.’s production capacity for sample collection and processing consumables. Hologic Inc. is now positioned to support the demand for COVID-19 testing in the United States due to the installed base of more than 1,100 fully automated, high throughput Panther and Panther Fusion systems. These Panther systems are each capable of performing more than 1,000 tests in a 24-hour period.
This effort has been led by the DOD’s Joint Acquisition Task Force in coordination with the Department of the Air Force’s Acquisition COVID-19 Task Force and funded through the Paycheck Protection Program and Health Care Enhancement Act to enable and support industrial base expansion for critical medical resources.
HHS_ASH So this is a platform for Trump advertisements? Disgraceful.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: YahooNews - 🏆 380. / 59 Read more »